Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.
about
Small glutamine-rich protein/viral protein U-binding protein is a novel cochaperone that affects heat shock protein 70 activityAn early stage of Mason-Pfizer monkey virus budding is regulated by the hydrophobicity of the Gag matrix domain coreUnderstanding the process of envelope glycoprotein incorporation into virions in simian and feline immunodeficiency virusesSingle-Cell and Single-Cycle Analysis of HIV-1 ReplicationLipids and membrane microdomains in HIV-1 replicationPoint Mutations in the HIV-1 Matrix Protein Turn Off the Myristyl SwitchEntropic switch regulates myristate exposure in the HIV-1 matrix proteinStructure of the Myristylated Human Immunodeficiency Virus Type 2 Matrix Protein and the Role of Phosphatidylinositol-(4,5)-Bisphosphate in Membrane TargetingTrio engagement via plasma membrane phospholipids and the myristoyl moiety governs HIV-1 matrix binding to bilayersBiophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix proteinEvolution of a species-specific determinant within human CRM1 that regulates the post-transcriptional phases of HIV-1 replicationDesign of in vitro symmetric complexes and analysis by hybrid methods reveal mechanisms of HIV capsid assemblyThe structural biology of HIV assembly.Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag.Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assayHow HIV-1 Gag assembles in cells: Putting together pieces of the puzzle.Anx2 interacts with HIV-1 Gag at phosphatidylinositol (4,5) bisphosphate-containing lipid rafts and increases viral production in 293T cellsBiochemical characterization of rous sarcoma virus MA protein interaction with membranes.Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates.Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag).The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process.Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging.SRp40 and SRp55 promote the translation of unspliced human immunodeficiency virus type 1 RNANuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein.The Role of Lipids in Retrovirus Replication.Knockdown of the cellular protein LRPPRC attenuates HIV-1 infection.Specificity of plasma membrane targeting by the rous sarcoma virus gag protein.Myristate exposure in the human immunodeficiency virus type 1 matrix protein is modulated by pH.Roles played by acidic lipids in HIV-1 Gag membrane bindingPhosphoinositides direct equine infectious anemia virus gag trafficking and release.Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding.HIV-1 Gag: flipped out for PI(4,5)P(2).Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.Matrix mediates the functional link between human immunodeficiency virus type 1 RNA nuclear export elements and the assembly competency of Gag in murine cells.Membrane binding and subcellular localization of retroviral Gag proteins are differentially regulated by MA interactions with phosphatidylinositol-(4,5)-bisphosphate and RNA.Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virionsGag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 GagMolecular determinants that regulate plasma membrane association of HIV-1 Gag
P2860
Q24563260-B9A728B5-917E-4CAC-A92F-AC4315EFF1C9Q24567661-05F7F4FE-AE7B-4494-B5B0-25EF5ECAC51EQ27021655-E2565352-4F41-44CC-9E13-1DE6D0168728Q27319151-2812024E-496F-4081-83FC-4398BF3E726DQ27489393-7B7C9AB7-72DF-4971-AC10-DDE3DDED36AEQ27640933-8E0461CC-D7E6-4EEF-9DE7-049CB5671ACAQ27642873-3E510943-B3D0-4E22-A7AD-66C21432BE45Q27651354-B4DFF1F4-CE4E-4D1D-BC85-428BED8E09E4Q27676343-5404D7C5-FA60-47EF-A2F5-2DDAEA3FF437Q27678797-2F9C043C-3B8D-4D54-9DB7-1315479BE4C2Q28742565-D74BB068-54E2-49F8-9F85-6E42BDCC6F49Q30425900-E40122F6-3A1C-49D9-8C3F-64D74634C4ABQ30437103-90650191-AD04-4476-8DDC-32EAA9A0360FQ30443327-BDDC0751-A8C7-4351-8AB0-CFDE6BF05052Q30447057-BD950E54-C373-45EA-90E6-D0D4DA7E37F4Q33358839-FE1F3368-FFE4-4D0A-93C2-04A77CBF842BQ33422993-10E8957D-729C-4C66-B883-B99AB4E67A2FQ33780632-044EA591-5DB3-45B3-81AC-3CFA0D73613EQ33787084-F11F60BE-90DD-49EA-BCDE-83B703749D17Q33800293-B29454A1-B668-4D33-B6B2-CFE15442B1D6Q33806395-2DEE79D1-D83E-4975-BECC-A27C36742B19Q33809347-E2BB4486-738C-40C0-A575-0DD3F7989150Q33841842-C9F2E242-E259-4D08-A6E1-E85BB412E147Q33874415-244647DF-DE40-4C0E-8F00-6ACC3D5CFD3DQ33990712-F5B0701C-A1E0-41D2-B390-C3D0B4BC1F73Q34021302-FEF29638-3940-4D55-8A95-7860E4860217Q34080779-646E5C97-BF1F-4AA4-A26D-718834E398FDQ34342115-73A6B570-D67F-4B84-9176-2DA1BEBB92C3Q34462319-0AF24872-8C9B-48F9-B416-45E3AC28C1FDQ34544143-64B28DF5-1DE9-4209-9C93-7FEBE288E1DFQ34615838-8EABB73D-7452-4774-A3A6-E7D63F9DEE11Q34723209-9F2154B0-D586-4EAD-9E1B-6BE738860A1EQ34978433-C93116E1-6224-4DA4-8ECD-A850B5617FA3Q34983799-8F6914D0-9A17-44CF-8C04-F7D0CB0A651CQ34984031-5471E44F-14D7-4F98-8C28-A626D3911512Q34987465-9FCCF208-1671-45A7-8162-C0265942ED8CQ35072137-7EF030F9-07AF-444B-BF25-BA26A69DCF97Q35075569-76E0873E-7205-4D87-8FB3-DE62C639CE46Q35076588-BB4734FF-238C-45EC-B9B9-06E675FA6816Q35113734-D9E50D7E-C7A5-45A8-AA57-824DFDA3422C
P2860
Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Opposing effects of human immu ...... del of gag membrane targeting.
@ast
Opposing effects of human immu ...... del of gag membrane targeting.
@en
type
label
Opposing effects of human immu ...... del of gag membrane targeting.
@ast
Opposing effects of human immu ...... del of gag membrane targeting.
@en
prefLabel
Opposing effects of human immu ...... del of gag membrane targeting.
@ast
Opposing effects of human immu ...... del of gag membrane targeting.
@en
P2860
P1433
P1476
Opposing effects of human immu ...... odel of gag membrane targeting
@en
P2093
H G Göttlinger
P2860
P304
P577
1999-04-01T00:00:00Z